Healhcare Analyst Stavropoulos discusses emerging targets with differentiated strategies in Alzheimer’s Disease with CEOO’Connell of Acumen Pharmaceuticals, CMO Moebius of Athira Pharma, CMO Palumbo of Biovie Pharmaceuticals, CEO Ricciardi of Cognition Therapetics on an Analyst/Industry conference call to be held on June 23 at 10:30 am. (Webcast Link):(https://cantor.zoom.us/webinar/register/WN_JCBSSsa6RrC-cwxlS6MZ_Q#/registration)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ABOS:
- Acumen to present topline results from Phase 1 study of ACU193
- Acumen Pharmaceuticals to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease During Featured Research Session at the Alzheimer’s Association International Conference (AAIC®) 2023
- Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
- Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference
- Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023